Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer

NCT04053101 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT04053101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04053101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of FDG-PET CT in the Management of Muscle Invasive Bladder Cancer
Lead sponsor
Institut Bergonié
Phase
Observational
Overall status
Completed
Start date
April 1, 2017
Completion date
August 31, 2019
Enrollment
130 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

muscle invasive bladder cancer